ATE125268T1 - Säureempfindliche subeinheit eines insulinähnlichen wachstumfaktors-bindeprotein- komplexes. - Google Patents

Säureempfindliche subeinheit eines insulinähnlichen wachstumfaktors-bindeprotein- komplexes.

Info

Publication number
ATE125268T1
ATE125268T1 AT89907392T AT89907392T ATE125268T1 AT E125268 T1 ATE125268 T1 AT E125268T1 AT 89907392 T AT89907392 T AT 89907392T AT 89907392 T AT89907392 T AT 89907392T AT E125268 T1 ATE125268 T1 AT E125268T1
Authority
AT
Austria
Prior art keywords
acid
binding protein
protein
insulin
protein complex
Prior art date
Application number
AT89907392T
Other languages
English (en)
Inventor
Robert Charles Baxter
Original Assignee
Cent Sydney Area Health Serv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cent Sydney Area Health Serv filed Critical Cent Sydney Area Health Serv
Application granted granted Critical
Publication of ATE125268T1 publication Critical patent/ATE125268T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4743—Insulin-like growth factor binding protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT89907392T 1988-07-15 1989-07-14 Säureempfindliche subeinheit eines insulinähnlichen wachstumfaktors-bindeprotein- komplexes. ATE125268T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPI931488 1988-07-15
AUPJ335089 1989-03-23

Publications (1)

Publication Number Publication Date
ATE125268T1 true ATE125268T1 (de) 1995-08-15

Family

ID=25643507

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89907392T ATE125268T1 (de) 1988-07-15 1989-07-14 Säureempfindliche subeinheit eines insulinähnlichen wachstumfaktors-bindeprotein- komplexes.

Country Status (8)

Country Link
US (1) US5936064A (de)
EP (1) EP0424416B1 (de)
JP (4) JP3178714B2 (de)
AT (1) ATE125268T1 (de)
CA (1) CA1341598C (de)
DE (1) DE68923556T2 (de)
HK (1) HK206196A (de)
WO (1) WO1990000569A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0531425B1 (de) * 1990-05-30 2002-08-14 The President And Fellows Of Harvard College Kombination aus IGF-I und TGF-beta zur Knochenregenerierung
US5212074A (en) * 1990-08-28 1993-05-18 Chiron Corporation Genetic material encoding new insulin-like growth factor binding protein igfbp-6
WO1992003152A1 (en) * 1990-08-28 1992-03-05 Chiron Corporation New insulin-like growth factor binding protein (igfbp-4)
US5210017A (en) * 1990-11-19 1993-05-11 Genentech, Inc. Ligand-mediated immunofunctional hormone binding protein assay method
US6326154B1 (en) 1990-11-19 2001-12-04 Genentech, Inc. Ligand-mediated immunofunctional hormone binding protein assay method
FI86777C (fi) * 1990-12-31 1992-10-12 Medix Biochemica Ab Oy Foerfarande foer diagnosticering av bristningen av fosterhinnorna samt reagensfoerpackning foer anvaendning daervid
DE69233155T2 (de) 1991-01-08 2004-06-03 Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville Insulinartigen wachstumsfaktor bindendes protein
US5187151A (en) * 1991-02-12 1993-02-16 Genentech, Inc. Use of binding protein with igf-i as an anabolic growth promoting agent
FI94181C (fi) 1992-06-29 1995-07-25 Medix Biochemica Ab Oy Diagnostinen menetelmä synnytysajankohdan ennustamiseksi sekä siihen käytettävä reagenssipakkaus
ATE243712T1 (de) 1992-11-04 2003-07-15 Chiron Corp Vekürztes insulinähnlichen wachstumsfaktor- bindendes protein mit mitogener aktivität
CA2154078A1 (en) * 1993-01-29 1994-08-04 George N. Cox Wound healing composition
US5747280A (en) * 1995-06-05 1998-05-05 Human Genome Sciences, Inc. Human vascular IBP-like growth factor
US5994302A (en) * 1994-12-09 1999-11-30 Human Genome Sciences, Inc. Human vascular IBP-like growth factor
WO1997035197A1 (en) * 1996-03-20 1997-09-25 Dyax Corp. PURIFICATION OF TISSUE PLASMINOGEN ACTIVATOR (tPA)
GB2321191B (en) * 1997-01-17 2000-09-27 Johnson & Johnson Medical Peptides for use in wound treatment
AUPR030900A0 (en) 2000-09-22 2000-10-12 Queensland University Of Technology Growth factor complex
US6875570B2 (en) 2000-09-27 2005-04-05 Curagen Corporation Proteins and nucleic acids encoding same
WO2002026826A2 (en) * 2000-09-27 2002-04-04 Curagen Corporation Proteins and nucleic acids encoding same
US7153691B2 (en) * 2002-11-13 2006-12-26 G6 Science Corp. Method of identifying and assessing DNA euchromatin in biological cells for detecting disease, monitoring wellness, assessing bio-activity, and screening pharmacological agents
US20100143442A1 (en) 2003-02-05 2010-06-10 Queensland University Of Technology Growth factor complexes and modulation of cell migration and growth
AU2003900481A0 (en) 2003-02-05 2003-02-20 Queensland University Of Technology Synthetic modulators of cell migration and growth
AU2003903896A0 (en) 2003-07-28 2003-08-07 Queensland University Of Technology Skin regeneration system
EP1670822A2 (de) 2003-10-03 2006-06-21 Genentech, Inc. Igf-bindende proteine
NZ600454A (en) 2009-11-30 2014-10-31 Univ Queensland Fibronectin: growth factor chimeras

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU627423B2 (en) * 1987-04-06 1992-08-27 Celtrix Pharmaceuticals, Inc. Human somatomedin carrier protein subunits and process for producing them
DK131988A (da) * 1988-03-11 1989-09-12 Erasmus University Igf-bindingsprotein, dna-struktur, der koder for igf-bindingsproteinet og vektor indeholdende denne dna-struktur
US5258287A (en) * 1988-03-22 1993-11-02 Genentech, Inc. DNA encoding and methods of production of insulin-like growth factor binding protein BP53
AU1955388A (en) * 1988-04-12 1989-11-03 Synergen, Inc. Method for potentiating and inhibiting insulin-like growth factor activity
US5324820A (en) * 1988-07-15 1994-06-28 Central Sydney Area Health Service Acid-labile subunit (ALS) of insulin-like growth factor binding protein complex
US5258257A (en) * 1991-09-23 1993-11-02 Shipley Company Inc. Radiation sensitive compositions comprising polymer having acid labile groups

Also Published As

Publication number Publication date
JP3178714B2 (ja) 2001-06-25
JPH03506030A (ja) 1991-12-26
EP0424416A1 (de) 1991-05-02
DE68923556D1 (de) 1995-08-24
JP2001252087A (ja) 2001-09-18
US5936064A (en) 1999-08-10
JP2003319791A (ja) 2003-11-11
EP0424416A4 (en) 1992-03-18
WO1990000569A1 (en) 1990-01-25
EP0424416B1 (de) 1995-07-19
HK206196A (en) 1996-11-22
DE68923556T2 (de) 1996-04-11
JP2005118052A (ja) 2005-05-12
CA1341598C (en) 2009-09-29

Similar Documents

Publication Publication Date Title
ATE125268T1 (de) Säureempfindliche subeinheit eines insulinähnlichen wachstumfaktors-bindeprotein- komplexes.
ATE194651T1 (de) Stammzellenfaktor
EP0434713A4 (en) Hiv-1 envelope muteins lacking hypervariable domains
IL154797A0 (en) Vascular endothelial cell growth factor that is unaccompanied by associated native glycosylation, pharmaceutical composition containing it and use thereof in the manufacture of a medicament for treating trauma affecting the vascular endothelium
ES2094159T3 (es) Produccion de factor de crecimiento de celulas endoteliales vasculares.
DK0402300T3 (da) Fremstilling i bakterier af gær og hæmoglobin og analoger dertil
FI885543A0 (fi) Dna-segment, polypeptider och anti-kroppar anslutande till human vaevnadsfaktor.
ATE76878T1 (de) Solubilisierung von protein-aggregaten.
EP0575546A4 (en) Prad1 cyclin and its cdna
ES2153816T3 (es) Adn que codifica un factor de crecimiento especifico contra celulas epiteliales.
DK408089D0 (da) Proteiner
DE69637844D1 (de) Neues tgf-beta-ahnliches cytokin
ATE274577T1 (de) Stammzellen-proliferations-faktor
EP0216742A3 (de) Wachstumsfaktoren
DE3650135D1 (de) Proteingewinnung.
DE69132530D1 (de) Heparin bindendes mitogen mit homologie zum epidermis wachstumsfaktor (egf)
BR9509172A (pt) Proteina de via de complemento nativa sequéncia de dna construção de dna conjugado uso de uma proteína processo para reduzir proteina de via de complemento em um mamifero e formulação farmacéutica
FR2662698B1 (de)
KR900002795A (ko) 하이브리드 단백질c 작제물 및 그들의 제조방법
ES2051830T3 (es) Solucion acuosa estable de anticuerpos.
DE69330352D1 (de) Mittel und methoden zur verbesserung der keratinocytenadhäsion an der haut
MX9203879A (es) Muteina de il-6 con cisteina parcialmente suprimida.
UA27048C2 (uk) Лікарський препарат імуhокоригуючої дії hа осhові клітиhhої суспеhзії, спосіб лікуваhhя цукрового діабету з використаhhям цього препарату
DE58909328D1 (de) Immunogen und seine Verwendung zur Gewinnung von Antikörpern gegen HbA1c.
EP0315118A3 (de) Endothelin kodierendes DNA und dessen Verwendung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time